Literature DB >> 8418502

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

J Trojan1, T R Johnson, S D Rudin, J Ilan, M L Tykocinski, J Ilan.   

Abstract

Rat C6 glioma cells express insulin-like growth factor I (IGF-I) and form rapidly growing tumors in syngeneic animals. When transfected with an episome-based vector encoding antisense IGF-I complementary DNA, these cells lost tumorigenicity. Subcutaneous injection of IGF-I antisense-transfected C6 cells into rats prevented formation of both subcutaneous tumors and brain tumors induced by nontransfected C6 cells. The antisense-transfected cells also caused regression of established brain glioblastomas when injected at a point distal to the tumor. These antitumor effects result from a glioma-specific immune response involving CD8+ lymphocytes. Antisense blocking of IGF-I expression may reverse a phenotype that allows C6 glioma cells to evade the immune system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418502     DOI: 10.1126/science.8418502

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  66 in total

1.  C6 rat glioma grown into the peritoneal cavity, a large source of tumoral cells for subcutaneous transplant of glioma.

Authors:  P Guevara; J Sotelo
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  The spherulites(TM): a promising carrier for oligonucleotide delivery.

Authors:  N Mignet; A Brun; C Degert; B Delord; D Roux; C Hélène; R Laversanne; J C François
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

Review 3.  Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.

Authors:  Steven De Vleeschouwer; Stefaan W Van Gool; Frank Van Calenbergh
Journal:  Childs Nerv Syst       Date:  2004-09-28       Impact factor: 1.475

4.  Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

Authors:  P Burfeind; C L Chernicky; F Rininsland; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 5.  Genomic stability and instability in different neuroepithelial tumors. A role for chromosome structure?

Authors:  L Manuelidis
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

Authors:  D Barba; J Hardin; M Sadelain; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival.

Authors:  Rainer Glass; Michael Synowitz; Golo Kronenberg; Joo-Hee Walzlein; Darko S Markovic; Li-Ping Wang; Daniela Gast; Jürgen Kiwit; Gerd Kempermann; Helmut Kettenmann
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

8.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

9.  Molecular characterization of defective antigen processing in human prostate cancer.

Authors:  M G Sanda; N P Restifo; J C Walsh; Y Kawakami; W G Nelson; D M Pardoll; J W Simons
Journal:  J Natl Cancer Inst       Date:  1995-02-15       Impact factor: 13.506

10.  Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.

Authors:  R A Gjerset; H Fakhrai; D L Shawler; S Turla; O Dorigo; A Grover-Bardwick; D Mercola; S F Wen; H Collins; H Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.